Answers are grounded in this paper and cite their sources.
Adapted with permission from Bykerk VP, Akhavan P, Hazlewood GS, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39(8):1559-82. Adapted with permission from Bombardier C, Hazlewood GS, Akhavan P, et al. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol 2012;39(8):1583-602.
No takes yet. Share an insight, caveat, or question.
Bornstein et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: